(0)

ViroCyt

ViroCyt is the leader in the field of rapid virus quantification. Our goal is to provide the tools that deliver meaningful improvements to mission critical processes, such as vaccine manufacturing, protein expression, antiviral development and other settings where viruses play a significant role.

Recent News

up
down
  • ViroCyt Releases ViroTag AAV2-3: Rapid and Direct Quantification of Gene Therapy Viral Vectors

    BOULDER, CO–(Marketwire – January 19, 2016) – ViroCyt, the leader in rapid virus quantification, announced today the release of the most recent addition to its ViroTag portfolio: ViroTag AAV2-3.  When combined with the Virus Counter 3100, this reagent enables real-time quantification of Adeno-associated virus serotypes 2 and 3, both of which are currently being developed as  Continue Reading »

    Read More arrow
  • ViroCyt Launches ViroTag for Direct, Real-Time, Antibody-Based Virus Quantification

    BOULDER, CO–(Marketwire – September 29, 2015) – ViroCyt, the leader in rapid virus quantification, announced today the introduction of a new paradigm in virus quantification building upon its award winning Virus Counter technology.  The importance of viruses as both a health threat and as a tool for addressing a growing list of diseases continues to increase  Continue Reading »

    Read More arrow
  • ViroCyt Appoints Greg Krueger to Lead Global Sales

    BOULDER, CO–(Marketwired – July 28, 2015) – ViroCyt, the leader in rapid virus quantification, announced today that Greg Krueger has joined the team as Vice President of Global Sales. Greg brings over 20 years of experience in the commercialization of life science products, including sales, marketing and business development roles at Sartorius Stedim Biotech, Becton Dickinson,  Continue Reading »

    Read More arrow
  • ViroCyt Raises $4 Million in New Financing

    BOULDER, CO–(Marketwire – June, 2015) – ViroCyt, the leader in rapid virus quantification, announced today that it has secured over $4 million in private investment. The financing was led by a strategic investor with significant participation by existing shareholders.  ViroCyt will use the capital to expand its global reach by adding new distributors in key markets,  Continue Reading »

    Read More arrow
  • Virus Quantification Symposium in Boston

    We are excited to announce our upcoming event: Virus Quantification Symposium in Boston. You are cordially invited to join us for a symposium on virus quantification on Tuesday, June 9 from 1pm-6pm at the Joseph B. Martin Conference Center at the Harvard Medical School in Boston, Massachusetts. For more information, please register here: http://goo.gl/YrHJvD

    Read More arrow

Upcoming Events


Mar
7

ISBioTech 6th Annual Spring Meeting Event Details

Mar
29

World Vaccine Congress US Event Details

May
4

American Society of Gene and Cell Therapy 19th Annual Meeting Event Details